Literature DB >> 24447319

Letter: Pitavastatin supplementation of PEG-IFN/ribavirin improves sustained virological response against HCV.

S Yokoyama1, Y Kawakami, K Chayama.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24447319     DOI: 10.1111/apt.12605

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  1 in total

1.  Statin (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor)-based therapy for hepatitis C virus (HCV) infection-related diseases in the era of direct-acting antiviral agents.

Authors:  Sara Sobhy Kishta; Sobhy Ahmed Kishta; Reem El-Shenawy
Journal:  F1000Res       Date:  2016-02-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.